Aphelion Capital

Biolinq Inc. is a San Diego-based company specializing in the development of innovative skin-applied electronic sensors designed to analyze body fluids and deliver health insights. Founded in 2012, Biolinq focuses on creating a digital health platform that facilitates biomonitoring solutions. Its flagship product is a minimally invasive electrochemical biosensor that continuously monitors various biomarkers in interstitial fluid, including glucose, ketones, and lactate. This technology enables diabetic patients to track their blood glucose levels without the discomfort associated with traditional monitoring methods. By providing actionable health information and insights, Biolinq aims to enhance metabolic health and improve the quality of life for individuals managing diabetes.

Biolinq Inc. is a San Diego-based company specializing in the development of innovative skin-applied electronic sensors designed to analyze body fluids and deliver health insights. Founded in 2012, Biolinq focuses on creating a digital health platform that facilitates biomonitoring solutions. Its flagship product is a minimally invasive electrochemical biosensor that continuously monitors various biomarkers in interstitial fluid, including glucose, ketones, and lactate. This technology enables diabetic patients to track their blood glucose levels without the discomfort associated with traditional monitoring methods. By providing actionable health information and insights, Biolinq aims to enhance metabolic health and improve the quality of life for individuals managing diabetes.

Koya Medical, Inc. is a healthcare company based in Oakland, California, founded in 2018. The company specializes in developing innovative wearable therapeutic devices aimed at treating cancer-related chronic lymphedema and various venous diseases. Koya Medical's technology offers active compression therapy that enhances mobility and personalized care, addressing limitations commonly associated with traditional compression methods. Its sensor-based closed-loop system provides patient-specific patterned compression, enabling healthcare providers to effectively manage conditions like chronic edema and chronic venous insufficiency. Through its breakthrough treatments, Koya Medical seeks to transform the standard of care for individuals affected by these debilitating conditions.

Biolinq Inc. is a San Diego-based company specializing in the development of innovative skin-applied electronic sensors designed to analyze body fluids and deliver health insights. Founded in 2012, Biolinq focuses on creating a digital health platform that facilitates biomonitoring solutions. Its flagship product is a minimally invasive electrochemical biosensor that continuously monitors various biomarkers in interstitial fluid, including glucose, ketones, and lactate. This technology enables diabetic patients to track their blood glucose levels without the discomfort associated with traditional monitoring methods. By providing actionable health information and insights, Biolinq aims to enhance metabolic health and improve the quality of life for individuals managing diabetes.

iHear Medical, Inc., established in 2010 and headquartered in San Leandro, California, specializes in developing and marketing affordable, web-enabled hearing aid solutions. The company offers a range of products, including iHEARhd (an invisible hearing aid for mild to moderate loss), iHEARMAX (a mini behind-the-ear option for adults with varying degrees of sensorineural, conductive, or mixed hearing loss profiles), Eva (a behind the ear hearing aid designed for women), and programmable digital hearing aids. These products are sold online and through select drugstores and pharmacies in the United States. iHear Medical's proprietary FDA Cleared iHEARtest is a direct-to-consumer at-home hearing screener, providing users with a Hearing Number™ to determine the most suitable hearing aid solution based on their degree of loss. The company aims to address barriers such as high cost and limited access to hearing aids, with over 50 patents submitted and 27 issued in its end-to-end closed business model. Founded by Adnan Shennib, a veteran of Silicon Valley medical device firms, iHear Medical's board comprises experienced venture capitalists and advisors from successful healthcare companies.

iHear Medical, Inc., established in 2010 and headquartered in San Leandro, California, specializes in developing and marketing affordable, web-enabled hearing aid solutions. The company offers a range of products, including iHEARhd (an invisible hearing aid for mild to moderate loss), iHEARMAX (a mini behind-the-ear option for adults with varying degrees of sensorineural, conductive, or mixed hearing loss profiles), Eva (a behind the ear hearing aid designed for women), and programmable digital hearing aids. These products are sold online and through select drugstores and pharmacies in the United States. iHear Medical's proprietary FDA Cleared iHEARtest is a direct-to-consumer at-home hearing screener, providing users with a Hearing Number™ to determine the most suitable hearing aid solution based on their degree of loss. The company aims to address barriers such as high cost and limited access to hearing aids, with over 50 patents submitted and 27 issued in its end-to-end closed business model. Founded by Adnan Shennib, a veteran of Silicon Valley medical device firms, iHear Medical's board comprises experienced venture capitalists and advisors from successful healthcare companies.

iHear Medical, Inc., established in 2010 and headquartered in San Leandro, California, specializes in developing and marketing affordable, web-enabled hearing aid solutions. The company offers a range of products, including iHEARhd (an invisible hearing aid for mild to moderate loss), iHEARMAX (a mini behind-the-ear option for adults with varying degrees of sensorineural, conductive, or mixed hearing loss profiles), Eva (a behind the ear hearing aid designed for women), and programmable digital hearing aids. These products are sold online and through select drugstores and pharmacies in the United States. iHear Medical's proprietary FDA Cleared iHEARtest is a direct-to-consumer at-home hearing screener, providing users with a Hearing Number™ to determine the most suitable hearing aid solution based on their degree of loss. The company aims to address barriers such as high cost and limited access to hearing aids, with over 50 patents submitted and 27 issued in its end-to-end closed business model. Founded by Adnan Shennib, a veteran of Silicon Valley medical device firms, iHear Medical's board comprises experienced venture capitalists and advisors from successful healthcare companies.

CyMedica Orthopedics, Inc. is a medical device company focused on developing and commercializing innovative products for joint injuries and the associated muscle atrophy. Founded in 2013 and based in Scottsdale, Arizona, CyMedica offers a range of orthopedic solutions that utilize proprietary neuromuscular electrical stimulation technology. Its flagship product, e-vive, provides individualized muscle stimulation therapy through a wireless and app-controlled system, allowing patients to engage in their rehabilitation while tracking progress and sharing data with clinicians. Additionally, the company offers a variety of products, including the Conductive garment, which ensures effective muscle activation, the ACL Brace for post-operative support, and The QB1 System, designed to empower patients in overcoming quadricep weakness. These devices aim to stabilize joints, prevent muscle weakening during recovery, and improve patient outcomes while reducing the likelihood of readmission.

iHear Medical, Inc., established in 2010 and headquartered in San Leandro, California, specializes in developing and marketing affordable, web-enabled hearing aid solutions. The company offers a range of products, including iHEARhd (an invisible hearing aid for mild to moderate loss), iHEARMAX (a mini behind-the-ear option for adults with varying degrees of sensorineural, conductive, or mixed hearing loss profiles), Eva (a behind the ear hearing aid designed for women), and programmable digital hearing aids. These products are sold online and through select drugstores and pharmacies in the United States. iHear Medical's proprietary FDA Cleared iHEARtest is a direct-to-consumer at-home hearing screener, providing users with a Hearing Number™ to determine the most suitable hearing aid solution based on their degree of loss. The company aims to address barriers such as high cost and limited access to hearing aids, with over 50 patents submitted and 27 issued in its end-to-end closed business model. Founded by Adnan Shennib, a veteran of Silicon Valley medical device firms, iHear Medical's board comprises experienced venture capitalists and advisors from successful healthcare companies.

VideoCare, Inc. is a technology company focused on enhancing connectivity between families and their aging loved ones through its innovative video communication solution. Founded in 2011 and based in Menlo Park, California, VideoCare offers a user-friendly touch-screen video system designed for elderly care recipients, eliminating the need for keyboards or technical skills. This system facilitates two-way video connections, allowing users to share photos, videos, and music, as well as track medication and appointments. VideoCare not only enables families to provide remote support and companionship but also assists professionals and care agencies in delivering care and maintaining communication with their clients. Through its technology, VideoCare aims to improve the quality of life for seniors by fostering meaningful connections with family and caregivers.

iHear Medical, Inc., established in 2010 and headquartered in San Leandro, California, specializes in developing and marketing affordable, web-enabled hearing aid solutions. The company offers a range of products, including iHEARhd (an invisible hearing aid for mild to moderate loss), iHEARMAX (a mini behind-the-ear option for adults with varying degrees of sensorineural, conductive, or mixed hearing loss profiles), Eva (a behind the ear hearing aid designed for women), and programmable digital hearing aids. These products are sold online and through select drugstores and pharmacies in the United States. iHear Medical's proprietary FDA Cleared iHEARtest is a direct-to-consumer at-home hearing screener, providing users with a Hearing Number™ to determine the most suitable hearing aid solution based on their degree of loss. The company aims to address barriers such as high cost and limited access to hearing aids, with over 50 patents submitted and 27 issued in its end-to-end closed business model. Founded by Adnan Shennib, a veteran of Silicon Valley medical device firms, iHear Medical's board comprises experienced venture capitalists and advisors from successful healthcare companies.